Bladder cancer survival statistics

Survival

Survive bladder cancer for 10 or more years, 2010-11, England and Wales

Age

Age that bladder cancer survival is highest, 2009-2013, England

 

Improvement

Bladder cancer survival in the UK has increased in the last 40 years

 

77% of men survive bladder cancer for at least one year, and this is predicted to fall to 57% surviving for five years or more, as shown by age-standardised Open a glossary item net survival for patients diagnosed with bladder cancer during 2010-2011 in England and Wales.[1] Survival for women is considerably lower, with 62% surviving for one year or more, and 46% predicted to survive for at least five years. The male survival advantage is seen in many countries across Europe,[2] and may be attributed in part to earlier diagnosis in men.[3,4]

Bladder Cancer (C67), Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 2010-2011

1-Year Survival (%) 5-Year Survival (%) 10-Year Survival (%)
Men Net Survival 76.6 56.9 54.3
95% LCL 76.6 56.7 53.9
95% UCL 76.6 57.1 54.8
Women Net Survival 61.6 45.6 39.5
95% LCL 61.5 45.2 38.8
95% UCL 61.8 46.1 40.2
Adults Net Survival 72.4 53.7 50.2
95% LCL 72.4 53.6 49.8
95% UCL 72.4 53.9 50.6

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item

Five- and ten-year survival is predicted using an excess hazard statistical model

Bladder cancer survival gradually continues to fall beyond five years after diagnosis, with the rate of decline being greater for women than for men. 54% of men and 40% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with bladder cancer during 2010-2011 in England and Wales.[1] Out of 20 common cancers in England and Wales, ten-year survival for bladder cancer ranks 11th highest overall.

Bladder Cancer (C67), Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales, 2010-2011

Survival for bladder cancer is reported in Scotland and Northern Ireland,[5,6] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses. There might also be underlying variation in classification and coding practices between UK countries.

References

  1. Data were provided by London School of Hygiene and Tropical Medicine on request, 2014.
  2. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931-91.
  3. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Maryland, US: National Cancer Institute; 2006.
  4. Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000;55(6):876-80.
  5. ISD Scotland. Trends in Cancer Survival 1983-2007.
  6. Northern Ireland Cancer Registry. Incidence & Survival 1993-2012.
Last reviewed:

Five-year survival for bladder cancer is generally higher in younger men and women and decreases with increasing age. Five-year net survival in men ranges from 73% in 15-49 year-olds to 43% in 80-99 year-olds for patients diagnosed with bladder cancer in England during 2009-2013.[1] In women, five-year survival ranges from 57% in 50-59 year-olds to 31% in 80-99 year-olds.

Bladder Cancer (C67), Five-Year Net Survival by Age, England, 2009-2013

Last reviewed:

Bladder cancer survival trends are difficult to interpret because of changes to classification and coding practices affecting the definition of invasive carcinoma of the bladder.The decrease in bladder cancer survival since the 1990s is likely to be due to an increasing proportion of bladder tumours now being coded as in situ or uncertain.

One-year age-standardised Open a glossary itemnet survival for bladder cancer in men has increased from 63% during 1971-1972 to 80% during 1990-1991 and then decreased to 77% during 2010-2011 in England and Wales.[1] In women, one-year survival has increased from 53% to 70% and then decreased to 62% over the same time periods.

Bladder Cancer (C67), Age-Standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Five-year age-standardised net survival for bladder cancer in men has increased from 41% during 1971-1972 to 63% during 1990-1991 and then decreased to a predicted survival of 57% during 2010-2011 in England and Wales.[1] In women, five-year survival has increased from 35% to 55% and then decreased to 46% over the same time periods.

Bladder Cancer (C67), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Five-year survival for 2010-2011 is predicted using an excess hazard statistical model

Ten-year age-standardised net survival for bladder cancer in men has increased from 34% during 1971-1972 to 54% during 1990-1991 and remained stable at a predicted survival of 54% during 2010-2011 in England and Wales.[1] In women, ten-year survival has increased from 29% to 49% and then decreased to 40% over the same time periods. Overall, half of people diagnosed with bladder cancer today are predicted to survive their disease for at least ten years.

Bladder Cancer (C67), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model

Last reviewed:

Survival for bladder cancer is strongly related to stage of the disease at diagnosis.

One year net survival for bladder cancer cancer is highest for patients diagnosed at stage I, and lowest for those diagnosed at stage IV, 2014 data for England show.[1] 94% of patients diagnosed at stage I survived their disease for at least one year, versus 33% diagnosed at stage IV.

One-year net survival for unknown stage bladder cancer is 55%. Lack of staging information may in some cases reflect advanced stage at diagnosis: for example very unwell patients may not undergo staging tests if the invasiveness of the testing outweighs the potential benefit of obtaining stage information.[1]

Bladder Cancer (C67), One-Year Age Standardised Net Survival by Stage, Adults (Ages 15-99 Years), England 2014

For patients diagnosed at stage II, one-year net survival is significantly higher for men than for women, with an absolute survival difference of 7 percentage points. One-year survival is similar between the sexes at all other stages.[1]

Five-year relative survival for bladder cancer in men ranges from 89% at Stage I to 9% at Stage IV for patients diagnosed during 2002-2006 in the former Anglia Cancer Network.[2] In women, five-year survival ranges from 86% at Stage I to 11% at Stage IV. There are no significant differences in five-year survival between men and women at any of the stages.

Bladder Cancer (C67, D090 and D141), Five-Year Relative Survival by Stage, Adults (Aged 15-99 Years), Former Anglia Cancer Network, 2002-2006

In this section, survival by stage is provided for the former Anglia Cancer Network in the east of England.[3]

References

  1. Office for National Statistics, Cancer survival by stage at diagnosis for England, 2016.
  2. Data were provided by The National Cancer Registration Service Eastern Office on request. Similar data can be found here: http://www.ncras.nhs.uk/ncrs-east/
  3. ISD Scotland. Trends in Cancer Survival 1983-2007.

About this data

Data is for: England, 2014 (one-year), Former Anglia Cancer Network, 2002-2006 (five-year), ICD-10 C67

Survival statistics give an overall picture of survival and the survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Last reviewed:

Five-year relative survival for bladder cancer in men in England (74%) is above the average for Europe (69%). Wales (74%) and Northern Ireland (79%) are also above the European average but Scotland (53%) is below the European average.[1] Across the European countries for which data is available, five-year relative survival in men ranges from 53% (Scotland) to 79% (Malta).[1]

Five-year relative survival for bladder cancer in women in England (67%) is similar to the average for Europe (66%). Wales (67%) and Northern Ireland (70%) are also similar to the European average but Scotland (42%) is below to the European average.[1] Across the European countries for which data is available, five-year relative survival in women ranges from 42% (Scotland) to 77% (Italy).[1

Bladder Cancer (C67), Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries, 2000-2007

Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.

Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.[1]

References

  1. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014;15:23-34

About this data

Data is for: 29 European countries, patients diagnosed in 2000-2007 and followed up to 2008, bladder cancer (International Classification of Diseases for Oncology [ICD-O-3] C67).

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Rate this page:

Currently rated: 1.8 out of 5 based on 13 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page